Clinical trial

The Viability-Guided Angioplasty After Acute Myocardial Infarction-Trial (The…

NCT00149591 · Netherlands Heart Foundation, Other · Unknown status

Key facts

NCT number NCT00149591
Title The Viability-Guided Angioplasty After Acute Myocardial Infarction-Trial (The VIAMI-Trial)
Official title Early and Long-Term Outcome of Elective Stenting of the Infarct-Related Artery in Patients With Viability in the Infarct-Area Early After Acute Myocardial Infarction. The VIAMI-Trial.
Lead sponsor Netherlands Heart Foundation, Other
Collaborators The Interuniversity Cardiology Institute of the Netherlands Eli Lilly and Company Industry Boehringer Ingelheim Bristol-Myers Squibb
Status Unknown status
Study type Interventional
Conditions Myocardial Infarction, Coronary Artery Disease
Intervention type Procedure
Interventions coronary balloon-angioplasty with stenting
Enrollment 300
Start date Apr 1, 2001
Completion Jan 1, 2007
First posted Sep 8, 2005
Last update posted Sep 5, 2008
Countries Netherlands

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies